Phase 3 Aspire study enrollment on track to complete in 2025 Aurora study to evaluate GTX-102 in other Angelman syndrome genotypes and ages expected to initiate later this year NOVATO, Calif., June 27 ...

Q&A with Model N's Michael Grosberg drills deeper into the new US drug pricing directives, including challenges in ...

Novo Nordisk plans to expand access to Wegovy through a collaboration with WeightWatchers, days after ending a partnership with telehealth firm Hims & Hers to sell the weight-loss drug.

Scientists have developed an innovative method to produce and rapidly analyze a vast array of macrocyclic peptides, molecules ...

Gulf Energy Information, a global leader in B2B media, data, and events for the process industries, announced a strategic media partnership with CompareNetworks, a premier media and technology company ...

To navigate the complexities of sophisticated drug development and manufacturing, a fundamental shift toward AI-powered ...

GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies, has transferred the upstream phase of the manufacturing process for LUMEVOQ, its gene ...

Experimental data on the effects that different antisolvents and antisolvent addition strategies have on nucleation behavior in antisolvent crystallization is very limited, and our understanding of ...

Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...

Time is of the essence for any cancer patient undergoing chemotherapy, so for that reason alone a substandard or ineffective ...

More data leads to more precise answers, and the biopharma industry has at its disposal more data than ever before.

Kennedy said that Pallone had previously been a champion of people who had been harmed by vaccines and only changed his tune ...